Healthcare Oct 26, 2021 04:18 PM (GMT+8) · EqualOcean
Financial Associated Press, October 26 - zoelli pharmaceutical announced that it is expected that the annual net profit attributable to the parent company will be 170 million yuan – 187 million yuan in 2021, with a year-on-year increase of 91.44% - 110.58%. During the reporting period, based on the advantages of Wuling capsule, bailing tablet and Lingze tablet entering the national catalogue of essential drugs, the company adhered to the marketing strategy of "stable self operation, strong investment promotion, cloth retail and full module", and continued to increase market investment and development coverage of terminal medical institutions.